Newsroom | 5039 results

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2025 financial results and provide a corporate update on February 24, 2026. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in numb...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in TD Cowen’s 46th Annual Health Care Conference. Reshma Kewalramani, President and Chief Executive Officer will participate in a fireside chat on Tuesday, March 3, 2026, at 9:10 a.m. ET. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com, in the "Investors" section under the "News and Events" page. A replay of the conference webcast...

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: Citi’s 2026 Unplugged MedTech and Life Sciences Access Day on Thursday, February 26, 2026 at 1:45pm Eastern Time (10:45am Pacific Time), TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 9:10am Eastern Time (6:10am Pacific Time), and Oppenhei...

SAN DIEGO--(BUSINESS WIRE)--Dexcom Reports Fourth Quarter and Fiscal Year 2025 Financial Results...

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2025, and provided its full year 2026 financial guidance. “2025 marked a year of strong revenue growth, commercial diversification, and pipeline advancement,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our focus in 2026 remains on executing across the CF franchise, bringing CASGEVY...

ROCK HILL, S.C.--(BUSINESS WIRE)--Vynleads (OTCQB: VYND) Launches AI-Powered Done With Diabetes™ App for Daily Blood Sugar and Metabolic Health Support...

MALVERN, Pa.--(BUSINESS WIRE)--LifeScan (“the “Company”), a world leader in glucose monitoring, today announced a transformational partnership with i-SENS, a global biosensor specialist, to launch a continuous glucose monitoring (“CGM”) system under the OneTouch® Vita brand. The Company and i-SENS expect to launch the CGM products in Germany, Ireland, Portugal, and Belgium by early 2027, with plans to expand into additional markets over time. This announcement reflects LifeScan’s long-term comm...

NEW YORK--(BUSINESS WIRE)--Cadence today announced new partnerships with Corewell Health, Sharp Rees-Stealy Medical Group, Village Medical, and Yale New Haven Health – a diverse group of academic medical centers, integrated delivery networks, and physician-led organizations taking a more proactive approach to senior care to improve outcomes, ease clinician burden, and help patients stay healthier at home. For seniors in these programs, care continues beyond the doctor’s office. A dedicated Cade...

SHANGHAI & BOSTON--(BUSINESS WIRE)--Eccogene Announces Positive Topline Results from Phase 1b Trial in China of Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist...

SAN FRANCISCO--(BUSINESS WIRE)--Vida Health today announced the expansion of its clinical portfolio to include support for patients living with MASH....